跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
甲磺酸多沙唑嗪控释片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Doxazosin Mesylate Controlled Release Tablets
Approved
化学药品
Doxazosin Mesylate Controlled Release Tablets
Pfizer AS
🇨🇳 National Medical Products Administration
Approval Date
Jun 29, 2001
Approval ID
7uctVAMUZcM
Company
Pfizer AS
Type
化学药品
Approval Details
Approval Id
7uctVAMUZcM
Approval Number
X20010202
Generic Name
甲磺酸多沙唑嗪控释片
Generic Name En
Doxazosin Mesylate Controlled Release Tablets
Drug Type
化学药品
Dosage Form
控释片剂
Strength
4mg/片
Reg Date
2001-06-29
Company Name
Pfizer AS
Production Company Address
Brooklyn,New York 11206
Company Detail Path
/organization/pfizer-as
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 29, 2001
Approval ID
7uctVAMUZcM
Type
化学药品
Back to NMPA Approvals
